Related material
The below resources contain further information about the impacts of COVID-19.
Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme service use
Web report
Last updated:
Citation
AIHW
Australian Institute of Health and Welfare (2020) Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme service use, AIHW, Australian Government, accessed 20 April 2024.
APA
Australian Institute of Health and Welfare. (2020). Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme service use. Retrieved from https://pp.aihw.gov.au/reports/health-care-quality-performance/covid-impacts-on-mbs-and-pbs
MLA
Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme service use. Australian Institute of Health and Welfare, 17 December 2020, https://pp.aihw.gov.au/reports/health-care-quality-performance/covid-impacts-on-mbs-and-pbs
Vancouver
Australian Institute of Health and Welfare. Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme service use [Internet]. Canberra: Australian Institute of Health and Welfare, 2020 [cited 2024 Apr. 20]. Available from: https://pp.aihw.gov.au/reports/health-care-quality-performance/covid-impacts-on-mbs-and-pbs
Harvard
Australian Institute of Health and Welfare (AIHW) 2020, Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme service use, viewed 20 April 2024, https://pp.aihw.gov.au/reports/health-care-quality-performance/covid-impacts-on-mbs-and-pbs